Geode Capital Management
ASTX

Geode Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Geode Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-434,563
Closed -$3.69M – 3810
2013
Q3 		$3.69M Buy
434,563
+22,915
+6% +$145K ﹤0.01% 1787
2013
Q2 		$1.69M Buy
+411,648
New +$2.21M ﹤0.01% 2143

Geode Capital Management's ASTX Position: Q4 2013 in Review

Geode Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 434,563 shares — an estimated $3.69M sold.

Geode Capital Management first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $3.69M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Geode Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Geode Capital Management sold 434,563 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $3.69M.
  • Geode Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Geode Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $3.69M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Geode Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.